Skip to main content
4SC AG logo

4SC AG — Investor Relations & Filings

Ticker · VSC ISIN · DE000A3E5C40 LEI · 391200QOKN7LGVP0RQ86 F Manufacturing
Open in API
Filings indexed 719 across all filing types
Latest filing 2014-03-31 AGM Information
Country DE Germany
Listing F VSC

About 4SC AG

https://www.4sc.com/

4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.

Recent filings

Filing Released Lang Actions
4 SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 09.05.2014 in Munchen mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 100% confidence The document is explicitly titled 'Einladung zur ordentlichen Hauptversammlung 2014' (Invitation to the Annual General Meeting 2014) and details the agenda (Tagesordnung) for the meeting scheduled for May 9, 2014. The agenda items cover standard AGM topics like approval of financial statements (TOP 1), discharge of management/supervisory boards (TOP 2 & 3), auditor appointment (TOP 4), remuneration system approval (TOP 5), and proposals for capital structure changes related to shareholder resolutions (TOP 6 & 7). This content directly corresponds to the materials presented or discussed at an Annual General Meeting. Therefore, the classification is AGM-R.
2014-03-31 German
4 SC AG: Veroffentlichung der Gesamtzahl der Stimmrechte nach 26a WpHG mit dem Ziel der europaweiten Verbreitung
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement from 4SC AG, dated March 31, 2014, regarding the 'Veröffentlichung der Gesamtzahl der Stimmrechte' (Publication of the total number of voting rights) according to § 26a WpHG. It explicitly states the total number of voting rights (50,408,654) as of the end of March 2014. This type of announcement, which reports on the total number of shares/voting rights, fits best under the category related to voting rights or general regulatory updates. Since there is no specific category for 'Total Voting Rights Announcement,' and it is a formal regulatory disclosure (WpHG reference), it is closest to Declaration of Voting Results & Voting Rights Announcements (DVA) or potentially a general Regulatory Filing (RNS). Given that it is a direct announcement of the current voting rights count, DVA is the most specific fit, as voting rights are intrinsically linked to shareholder voting mechanisms, even if it's not the *result* of a vote, but the *basis* for one. However, looking closely at the definitions, DVA is for 'Official results from shareholder votes at any general meeting.' This document is a mandatory disclosure of the total share capital/voting rights count, which is often a prerequisite for shareholder meetings but is a distinct regulatory filing type in many jurisdictions. Since it doesn't fit DVA perfectly (no vote result), and it's a specific regulatory disclosure, RNS (Regulatory Filings / miscellaneous filings) is a strong candidate. Let's re-evaluate DVA vs RNS. DVA is for results. This is a total count disclosure. Given the options, and the nature of mandatory disclosures not covered elsewhere, RNS is the safest fallback. However, if we consider the closest thematic fit, DVA relates to voting structure. Let's check if any other category fits better. It is not an ER, IR, 10-K, or CT. It is a regulatory disclosure. I will classify it as RNS as it is a general regulatory announcement that doesn't fit the specific voting *result* category (DVA).
2014-03-31 German
Press Release: 4SC publishes results for financial year 2013 and announces changes to the Management Board
Earnings Release Classification · 100% confidence The document explicitly states it 'published the financial results of the 4SC Group for the financial year ended 31 December 2013.' It contains detailed financial summaries, segment reporting (Development and Discovery & Collaborative Business), key business events for the year, and an outlook for 2014. The length (21,741 chars) is substantial, indicating a comprehensive report rather than a brief announcement. Although it also mentions management board changes, the primary focus and bulk of the content revolve around the full-year financial performance, which aligns best with the Annual Report (10-K) definition, even if the company might file a formal 10-K separately. Given the comprehensive nature of the 'results for financial year 2013,' it functions as the primary annual financial disclosure. FY 2013
2014-03-26 English
Press Release: 4SC Discovery collaborates with Heidelberg University Hospital and receives EUR 1.3 million for research and preclinical development of new malaria drug
Regulatory Filings Classification · 100% confidence The document is explicitly titled "Press Release" and details a collaboration, funding receipt (EUR 1.3 million government grant), and research progress regarding a malaria drug. It contains standard press release elements like a date, headline, quotes from management, and boilerplate information about the companies involved. This content structure strongly indicates an announcement of business development or operational news, rather than a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR). Since it is a general corporate announcement disseminated via a news service (DGAP), and it doesn't fit the specific categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), the most appropriate general category for non-standard corporate news announcements is Regulatory Filings (RNS), which serves as a broad category for official company news releases that aren't covered by more specific codes.
2014-03-20 English
Announcement: 4SC to host conference call on 26 March 2014 to present annual results 2013
Report Publication Announcement Classification · 99% confidence The document is a press release dated March 19, 2014, announcing that 4SC AG will present its annual results for 2013 and publish its Annual Report 2013 on March 26, 2014, via a conference call. The core purpose of this specific document is to announce the upcoming release of the results and the associated conference call details, rather than being the full Annual Report (10-K) or the Earnings Release (ER) itself. Since it is an announcement about the publication of a report and the scheduling of an event related to results, it fits best under Report Publication Announcement (RPA) or potentially a Regulatory Filing (RNS) if RPA wasn't available. Given the specific mention of announcing the publication of the Annual Report and hosting a call, RPA is the most precise fit, as it signals the impending release of the actual financial documents.
2014-03-19 English
4SC AG issues first tranche of convertible notes with a nominal amount of EUR 500,000 to Yorkville
Capital/Financing Update Classification · 95% confidence The document is explicitly labeled as an 'Ad-hoc' announcement dated March 4, 2014, disseminated pursuant to Section 15 of the German Securities Trading Act (WpHG). The content details a specific corporate action: the issuance of the first tranche of convertible notes to Yorkville. This type of immediate, material corporate event disclosure, which is not a full periodic report (like 10-K or IR) or a standard shareholder communication (like DEF 14A or AGM-R), fits best under the general regulatory announcement category. Since it is a specific, material, non-standard announcement, and not a standard periodic report, 'RNS' (Regulatory Filings) is the most appropriate fallback, as it covers general regulatory announcements that don't fit other specific codes like CAP or SHA, although this event relates to financing (CAP). Given the context of immediate, ad-hoc disclosure mandated by securities law, RNS is a strong fit, but since it specifically concerns financing/capital structure changes (issuance of convertible notes), 'CAP' (Capital/Financing Update) is more precise than the general 'RNS'.
2014-03-04 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.